A new categorization of HLA DR alleles on a functional basis

Human Immunology

Volumn 59, Issue 10, 1998, Pages 665-676

  Ou, Dawei ^a   Mitchell, Leslie Ann ^a   Tingle, Aubrey J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANTIGEN PRESENTATION; AUTOIMMUNITY; DISEASE PREDISPOSITION; HLA SYSTEM; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031751274     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00067-6     Document Type: Article

References (94)

1. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol. 56:1994;389-466.
2. Nepom G.T., Ehrlich H. MHC class II molecules and autoimmunity. Ann Rev Immunol. 9:1991;493-5251.
3. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis . Arthritis Rheum. 30:1987;1205-1213.
4. Hughes A.L., Yeager M., Carrington M. Peptide binding function and the paradox of HLA disease associations. Immunol Cell Biol. 74:1996;444-448.
5. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215-221.
6. Fu X.-T., Bono C.P., Woulfe S.L., Swearingen C., Summers N.L., Sinigaglia F., Sette A., Schwartz B.D., Karr R.W. Pocket 4 of the HLA-DR (α,β*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med. 181:1995;915-926.
7. Olson R.R., De Magistris M.T., Di Tommaso A., Karr R.W. Mutations in the third, but not the first or second, hypervariable regions of DR(1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol. 148:1992;2703-2708.
8. Ou D., Mitchell L.A., Domeier M.E., Tsang A.O.W., Décarie D., Nepom G.T., Lacroix M., Zrein M. Characterization of HLA restrictive elements of rubella virus-specific cytotoxic T-cell clone influence of HLA-DR4β chain residue 74 polymorphism on Ag peptide-T cell interaction . Int Immunol. 8:1996;1577-1586.
9. Olson R.R., Reuter J.J., McNicholl J., Alber C., Klohe E., Callahan K., Siliciano R.F., Karr R.W. Acidic Residues in the DRβ chain third hypervariable region are required for stimulation of a DR(α,β1*0402)-restricted T-cell clone. Hum Immunol. 41:1994;193-200.
10. Martinez-Soria E., Steimle V., Burkhardt C., Beffy P., Tiercy J.-M., Epplen J.T., Mach B., Irlé C. An HLA-DRB α-helix motif share by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell lines. Hum Immunol. 40:1994;279-290.
11. Marsh S.G.E., Bodmer J.G. HLA class II region nucleotide sequences, 1995. Tissue Antigens. 45:1995;258-280.
12. Ou D., Mitchell L.A., Ho M., Décarie D., Tingle A.J., Nepom G.T., Lacroix M., Zrein M. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelop protein influence of HLA-DR polymorphism of T-cell clonal recognition . Hum Immunol. 39:1994;177-187.
13. Ou D., Mitchell L.A., Tingle A.J. HLA-DR restrictive supertype dominate promiscuous T cell recognition association of multiple HLA-DR molecules with susceptibility to autoimmune diseases . J Rhenmatol. 24:1997;253-261.
14. Boehncke W.-H., Takeshita T., Pendleton C.D., Houghten R.A., Sadegh-Nasseri S., Racioppi L., Berzofsky J.A., Germain R.N. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol. 150:1993;331-341.
15. Wucherpfennig K.W., Strominger J.L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules mechanism for MHC-linked susceptibility to human autoimmune diseases . J Immunol. 181:1995;1597-1602.
16. Hammer J., Gallazzi F., Bono E., Karr R.W., Guenot J., Valsasnini P., Nagy Z.A., Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules correlation with rheumatoid arthritis association . J Exp Med. 181:1995;1847-1855.
17. Wecherpfennig K.W., Yu B., Bhol K., Monos D.S., Argyris E., Karr R.W., Ahmed A.R., Strominger J.L. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA. 92:1995;11935-11939.
18. Rammensee H.-G., Friede T., Stevanovic S. MHC ligands and peptide motifs first listing . Immunogenetics. 41:1995;178-228.
19. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells . Eur J Immunol. 19:1989;2237-2242.
20. Zeliszewski D., Gaudebout P., Golvano J.J., Dorval I., Prevost A., Borras-Cuesta F., Sterkers G. Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules. Hum Immunol. 41:1994;28-33.
21. Rees A.D.M., Lombardi G., Scoging A., Barber L., Mitchell D., Lamb J., Lechler R. Functional evidence foe the recognition of endogenous peptide by autoreactive T cell clones. Int Immunol. 1:1989;624-630.
22. Lombardi G., Sidhu S., Batchelor J.R., Lechler R.I. Allorecognition of DR1 by T cell from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptide. Proc Natl Acad Sci USA. 86:1989;4190-4194.
23. Lamb J.R., Rees A.D.M., Bal V., Ikeda H., Wilkinson D., De Vries R.R.P., Rothbard J.B. Prediction and identification of an HLA-DR restricted T cell determinant in the 19 KDa protein of mycobacterium tuberculosis. Eur J Immunol. 18:1988;973-976.
24. + cytotoxic T cell clones reactive to capsid antigen of rubella virus. Virol. 191:1992;680-686.
25. Rothbard J.B., Busch R., Bal V., Trowsdale J., Lechler R.I., Lamb J.R. Reversal of HLA restriction by a point mutation in an antigenic peptide. Int Immunol. 1:1989;487-495.
26. Karr R.W., Panina-Bordignon P., Yu W.-Y., Lanzavecchia A. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DRβ chain substitutions. J Immunol. 146:1991;4242-4247.
27. Zeliszewski D., Golvano J.J., Gaudebout P., Dorval I., Borras-Cuesta F., Sterkers G. Binding of Ala-substituted analogs of HA306-320 to DR1101, DR1301, and DR0402 molecules correlation of DR-peptide interactions with recognition by a single TCR . Hum Immunol. 50:1996;61-69.
28. Chauhan B., Knutsen A.P., Hutcheson P.S., Slavin R.G., Bellone C.J. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 97:1996;2324-2331.
29. Wucherpfennig K.W., Sette A., Southwood S., Oseroff C., Matsui M., Strominger J.L., Hafler D.A. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med. 179:1994;279-290.
30. Ou D., Chong P., Tripet B., Gillam S. Analysis of T-and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides. J Virol. 66:1992;1674-1681.
31. Ou D., Mitchell L.A., Décarie D., Tingle A.J., Nepom G.T. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing a HLA supertype. Human Immunol. 59:1998;149-157.
32. Malcherek G., Gnau V., Stevanovic S., Rammensee H.-G., Lung G., Melms A. Analysis of allele- specific contact sites of natural HLA-DR17 ligands. J Immunol. 153:1994;1141-1149.
33. Haas J.P., Truckenbrodt H., Paul C., Hoza J., Scholz S., Albert E.D. Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin Exp Rheumatol. 12:(suppl. 10):1994;S7-S14.
34. Okubo H., Itou K., Tanaka S., Watanabe N., Kashiwagi N., Obata F. Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. Rheumatol Int. 13:1993;65-69.
35. Nepom B.S., Glass D.N. Juvenile rheumatoid arthritis and HLA Report of the park city III workshop . J Rheumatol. 19:(suppl. 33):1992;70-74.
36. Nepom B. The Immunogenetics of juvenile rheumatoid arthritis. Rheum Dis Clin North Am. 17:1991;825-841.
37. Ploski R., Vinje O., Rφnningen K.S., Spurkland A., Sφrskaar D., Vartdal F., Forre O. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. Arthritis Rheum. 36:1993;465-472.
38. Grom A.A., Giannini E.H., Glass D.N. Juvenile rheumatoid arthritis and the trimolecular complex (HLA, T cell receptor, and antigen). Arthritis Rheum. 37:1994;601-607.
39. Tan P.L.J., Farmiloe S., Roberts M., Geursen A., Skinner M.A. HLA-DR4 subtypes in New Zealand polynesians predominance of Dw13 in the healthy population and association of Dw15 with rheumatoid arthritis . Arthritis Rheum. 36:1993;15-19.
40. Davenport M.P., Godkin A., Friede T., Stevanovic S., Willis A.C., Hill A.V.S., Rammensee H.-G. A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis. Immunogenetics. 45:1997;229-232.
41. Rigby A.S., Silman A.J., Voelm L., Gregory J.C., Ollier W.E.R., Khan M.A., Nepom G.T., Thomson G., Tokano Y., Murashima A., Kabasawa K., Hirose S. Investigating the HLA component in rheumatoid arthritis an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred . Genet Epidemiol. 8:1991;153-175.
42. Seglias J., Li E.K., Cohen M.G., Wong R.W.S., Potter P.K., So A.K. Linkage between rheumatoid arthritis susceptibility and the presence of HLA-DR4 and DRβ allelic third hypervariable region sequences in southern chinese persons. Arthritis Rheum. 35:1992;163-167.
43. Boki K.A., Panayi G.S., Vaughan R.W., Drosos A.A., Moutsopoulos H.M., Lanchbury J.S. HLA- class II sequence polymorphism and susceptibility to rheumatoid arthritis in greeks the HLA-DRβ share-epitope hypothesis accounts for the disease in only a minority of Greek patients . Arthritis Rheum. 35:1992;749-755.
44. Haas J.-P., Nevinny-Stickel C., Schoenwald U., Truckenbrodt H., Suschke J., Albert E.D. Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol. 41:1994;225-233.
45. Chauhan B., Santiago L., Kirschmann D.A., Hauptfeld V., Knutsen A.P., Hutcheson P.S., Woulfe S.L., Slavin R.G., Schwartz H.J., Bellone C.J. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol. 159:1997;4072-4076.
46. Moraes M.E., Fernandez-Viña M., Stastny P. DNA typeing for class II HLA antigens with allele- specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group. Human Immunol. 31:1991;139-144.
47. Mitchell L.A., Tingle A.J., MacWilliam L., Horne C., Keown P., Gaur L.K., Nepom G.T. HLA-DR class II association with rubella vaccine-induced joint manifestations. J Infect Dis. 177:1998;5-12.
48. Wan X.-L., Kimura K., Dong R.-P., Honda K., Tamai H., Sasazuki T. HLA-A and -DRB4 gene in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol. 42:1995;131-136.
49. Wang F.W., Yu Z.Q., Xy J.J., Wang X.L., Zhang D.Q., Chen J.L. HLA and hypertrophic Hashimoto's thyroiditis in Shanghai Chinese. Tissue Antigen. 32:1988;235-236.
50. Hawkins B.R., Lam K.S.L., Ma J.T.C., Wang C., Yeung R.T.T. Strong association between HLA DRw9 and Hashimoto's thyroiditis in southern Chinese. Endocrinologica. 114:1987;543-546.
51. Tandon N., Zhang L., Weetman A.P. HLA association with Hashimoto's thyroiditis. Clin Endocrinol. 34:1991;383-386.
52. Farid N.R., Sampson L., Moens H., Barnard J.M. The association of goitrous thyroiditis with HLA-DR5. Tissue Antigen. 17:1981;265-268.
53. Cowland J.B., Andersen V., Halberg P., Morling N. DNA polymorphism of HLA class II genes in systemic lupus erythematosus. Tissue Antigen. 43:1994;34-37.
54. Skarsvåg S., Hansen K.E., Holst A., Moen T. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): An increased risk of SLE among non[DRB1*03, DQA1*0501, DQB1*0201] Class II homozygotes? Tissue Antigen. 40:1992;128-133.
55. Hashimoto H., Nishimura Y., Dong R.P., Kimura A., Sasazuki T., Yamanaka K., et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol. 23:1994;191-196.
56. Doherty D.G., Ireland R., Demaine A.G., Wang F., Veerapan K., Welsh K.I., Vergani D. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum. 35:1992;641-646.
57. Barron K.S., Silverman E.D., Gonzales J., Reveille J.D. Clinical serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 36:1993;348-354.
58. Hartung K., Baur M.P., Coldewey R., Fricke M., Kalden J.R., Lakomek H.J., Feter H.H., Schendel D., Schneider P.M., Seuchter S.A., Standel W., Deicher H.R.G. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. J Clin Invest. 90:1992;1346-1351.
59. Yao Z., Kimura A., Hartung K., Hass P.J., Volgger A., Brünnler G., Bönisch J., Albert E.D. Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. Immunogenetics. 38:1993;421-429.
60. Farid NR, Shi YF, Zou MJ, Stensky V, Wu Z, Stephens HAF, Bottazzo GF: Hashimoto's thyroiditis is associated with different MHC class II loci. In Tsuji K, Aizawa M, and Sasazuki T (eds): HLA 1991, Vol 1. Oxford University Press. Oxford. 1991; pp759-761.
61. Krueger G.G., Duvic M. Epidemiology of Psoriasis Clinical Issues . J Invest Dermatol. 102:1994;15S-18S.
62. Marcusson J.A., Möller E. Further studies on psoriasis-associated HLA-Dw/DR7 using PLT cells primed against a familial psoriasis linked HLA haplotype. Tissue Antigens. 27:1986;1-9.
63. Haegert DG, Marrosu MG: Genetic susceptibility to multiple sclerosis. Ann Neurol 36(suppl. 2):S204-S210, 1994.
64. Chelvanayagam G. A Roadmap for HLA-DR peptide binding specificities. Human Immunol. 58:1997;61-69.
65. Thorsby E., Undlien D. The HLA association to type 1 diabetes and other autoimmune diseases. J Ped Endocrinol Metabol. 9:1996;75-88.
66. Erlich H.A., Rotter J.I., Chang J., Shaw S., Raffel L.J., Klitz W., Beshkov Y., Costin G., Pressman S., Bugawan T., Rotter J.I. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican American families. Not Genet. 3:1993;358-364.
67. Huang H.S., Peng J.T., She J.Y., Zhang L.-P., Chao C.C.K., Liu K.-H., She J.-X. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determine by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Human Immunol. 44:1995;210-219.
68. Cucca F., Lampis R., Frau F., Macis D., Angius E., Masile P., Chessa M., Frongia P., Silvetti M., Cao A., De Virgiliis S., Congia M. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type 1 diabetes with DRB1 and DQB1 loci. Human Immunol. 43:1995;301-308.
69. Thomson G., Robinson W.P., Kuhner M.K., Joe S., MacDonald M.J., Gottschall J.L., Barbosa J., Rich S.S., Bertrams J., Baur M.P., Partanen J., Tait B.D., Schober E., Mayr W.R., Ludvigsson J., Lindblom B., Farid N.R., Thompson C., Deschamps I. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 43:1988;799-816.
70. She J.X. Susceptibility to type I diabetes HLA-DQ and DR revisited . Immunol Today. 17:1996;323-329.
71. Zeliszewski D., Tiercy J.-M., Boitard C., Gu X.-F., Loche M., Krishnamoorthy R., Simonney N., Elion J., Bach J.-F., Mach B., Sterkers G. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. Human Immunol. 33:1992;140-147.
72. Kisielow P., Teh H.S., Bluthmann H., von Boehmer H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 335:1988;730-733.
73. Fugger L., Michie S.A., Rulifson I., Lock C.B., McDevitt G.S. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci USA. 91:1994;6151-6155.
74. Bill J., Ronchese F., Germain R.N., Palmer E.D. The contribution of mutant amino acid to alloantigenicity. J Exp Med. 170:1989;739-750.
75. + cells sensitized to nicotinic acetylcholine receptor. J Immunol. 147:1991;1484-1491.
76. Gulwani-Akolkar B., Shi B., Akolkar P.N., Ito K., Bias W.B., Silver J. Do HLA genes play a prominent role in determining T cell receptor Vα segment in humans. J Immunol. 154:1995;3843-3851.
77. Walser-Kuntz D.P., Weyand C.M., Fulbright J.W., Moore S.B., Goronzy J.J. Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Human Immunol. 44:1995;203-209.
78. Thompson S.D., Grom A.A., Bailey S., Luyrink L., Giannini E.H., Murray K., Passo M.H., Lovell D.J., Choi E., Glass D.N. Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J Rheumatol. 22:1995;1356-1364.
79. Walser-kuntz D.R., Weyand C.M., Weaner A.J., O'fallon W.M., Gorinzy J.J. Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity. 2:1995;597-605.
80. Penzotti J.E., Nepom G.T., Lybrand T.P. Use of T cell receptor/HLA-DRB1*04 molecular modelling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum. 40:1997;1316-1326.
81. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 94:1994;2125-2129.
82. Jones D.B., Crosby I. Proliferative lymphocyte responses to virus antigens homologous to DAD65 in IDDM. Diabetologia. 39:1996;1318-1324.
83. Honeyman M.C., Cram D.S., Harrison L.C. Glutamic acid decarboxylase 67-reactive T cells a marker of insulin-dependent diabetes . J Exp Med. 177:1993;535-540.
84. Lohmann T., Leslie R.D.G., Hawa M., Geysen M., Rodda S., Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 343:1994;1607-1608.
85. Wicker L.S., Chen S.-L., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., Zheng S., Herman A., Lernmark A., Zaller D.M., Peterson L.B., Rothard J.B., Cummings R., Whiteley P.J. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest. 98:1996;2597-2603.
86. Congia M., Patel S., Cope A.P., De Virgiliis S. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA. 95:1998;3833-3838.
87. Rosloniec E.F., Brand D.D., Myers L.K., Esaki Y., Whittington K.B., Zaller D.M., Woods A., Stuart J.M., Kang A.H. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol. 160:1998;2573-2578.
88. Neophytou P.I., Roep B.O., Arden S.D., Muir E.M., Duinkerken G., Kallan A., de Vries R.R.P., Hutton J.C. T-cell epitope analysis using subtracted expression libraries (TEASEL) application to a 38-KDa autoantigen recognized by T cells from an insulin-dependent diabetic patient . Proc Natl Acad Sci USA. 93:1996;2014-2018.
89. Lohmann T., Leslie R.D.G., Londei M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmunity. 9:1996;385-389.
90. Rosloniec E.F., Brand D.D., Myers L.K., Whittington K.B., Gumanovskaya M., Zaller D.M., Woods A., Altmann D.M., Stuart J.M., Kang A.H. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 185:1997;1113-1122.
91. Wucherpfennig K.W., Hafler D.A., Strominger J.L. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide positioning of T-cell receptor on HLA-DR2 complexes . Proc Natl Acad Sci USA. 92:1995;8896-8900.
92. Prabhu Das M., Nicholson L.B., Greer J.M., Kuchroo V.K. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J Exp Med. 186:1997;867-876.
93. Trotter J.L., Damico C.A., Cross A.H., Pelfrey C.M., Karr R.W., Fu X.-T., McFarland H.F. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides. J Neuroimmunol. 75:1997;95-103.
94. Zerva L., Cizman B., Mehra N.K., Alahari S.K., Murali R., Zmijewski C.M., Kamoun M., Monos D.S. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med. 183:1996;829-836.